Iron Status and Human Metabolism

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Iron Deficiency
Interventions
DRUG

Ferric carboxymaltose

Infusion of 15 mg/kg (up to maximum 1000 mg) ferric carboxymaltose in 250 mL 0.9% sodium chloride

DRUG

Sodium chloride (placebo)

Infusion of 250 mL 0.9% sodium chloride

Trial Locations (1)

OX3 9DU

University of Oxford OCMR & CCRF, John Radcliffe Hospital, Oxford

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University of Oxford

OTHER

NCT02308449 - Iron Status and Human Metabolism | Biotech Hunter | Biotech Hunter